![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 35, 26812-26820, September 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Chemistry and Biochemistry, University of
Colorado, Boulder, Colorado 80309-0215 and the
Previous studies in our laboratory have
characterized 3'-azido-3'-deoxythymidine (AZT) as a potent inhibitor of
glycosphingolipid biosynthesis in cultured cells (Steet, R., Alizadeh,
M., Melançon, P., and Kuchta, R. D. (1999) Glycoconj.
J. 16, 237-245; Yan, J.-P., Ilsley, D. D., Frohlick, C.,
Steet, R., Hall, E. T., Kuchta, R. D., and Melançon, P. (1995) J. Biol. Chem. 270, 22836-22841). Here, we
report that AZT treatment of K562 cells results in significant alterations in the profile of N-linked oligosaccharides.
Fractionation of [3H]mannose-labeled oligosaccharides
from AZT-treated K562 cells using lectin affinity chromatography
revealed striking changes in the branching and processing of
N-linked glycoconjugates. AZT treatment resulted in the
production of fewer highly branched complex glycans (60% of control at
20 µM AZT) and a significant accumulation of
core-fucosylated biantennary oligosaccharides. In addition, extension
of branched oligosaccharides with multiple poly-N-acetyllactosamine repeats is nearly abolished by AZT
concentrations as low as 2 µM. A shift from
multiantennary to moderately branched oligosaccharides was also
apparent in the melanoma cell line SK-MEL-30 upon AZT treatment.
N-Linked glycans from both cell lines exhibited increased
affinity for the
3'-Azidothymidine Potently Inhibits the Biosynthesis of
Highly Branched N-Linked Oligosaccharides and
Poly-N-acetyllactosamine Chains in Cells*
§, and
Department of Cell Biology and Anatomy, University of
Alberta, Edmonton AB T6G2H7, Canada
-galactoside-binding lectin RCA-I in the presence
of AZT, suggesting that the addition of terminal sialic acid is
sensitive to the drug. These results demonstrate the ability of AZT to
modulate strongly the processing of asparagine-linked glycoconjugates
in whole cells and reveal a novel mechanism by which AZT treatment may
cause anemia.
*
This work was supported by Grant GM55709 from the National
Institutes of Health (to R. D. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. Lanteri, V. Giordanengo, N. Hiraoka, J.-G. Fuzibet, P. Auberger, M. Fukuda, L. G. Baum, and J.-C. Lefebvre Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death Glycobiology, December 1, 2003; 13(12): 909 - 918. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |